Refractory macular hole repaired by autologous retinal graft and blood clot

BMC Ophthalmology
An-Lun WuChi-Chun Lai

Abstract

To evaluate the surgical technique using autologous retinal graft (ARG) and autologous blood clot (ABC) for the management of refractory macular holes (MHs). This study was a retrospective, consecutive, interventional case series. Six eyes of 6 patients who underwent vitrectomy combined with ARG and ABC for the treatment of refractory MH were reviewed. Visual and anatomic outcomes were evaluated. The mean age was 59.0 ± 9.9 years. All cases had multiple vitreoretinal procedures including vitrectomy and gas fluid exchange before patient presentation. The average numbers of vitrectomies were 2.3 ± 0.5, and those of gas fluid exchange were 3 ± 1.7. Closure of the macular hole was achieved in four (66.7%) cases at last follow-up. The mean follow-up time was 25.2 ± 15.6 months. The averaged BCVA before and after 12 months of the surgery improved from 20/591 to 20/244. This surgical technique using ARG and ABC provide an option for the treatment of refractory MHs.

References

May 1, 1991·Archives of Ophthalmology·N E Kelly, R T Wendel
Dec 1, 1982·American Journal of Ophthalmology·H Glatt, R Machemer
Nov 6, 2008·Acta Ophthalmologica·Alexandra LappasBernd Kirchhof
Jun 15, 2010·Ophthalmology·Zofia MichalewskaJerzy Nawrocki
May 22, 2013·American Journal of Ophthalmology·Xi RaoChi-Chun Lai
Jan 15, 2014·American Journal of Ophthalmology·Yuki MorizaneToshio Okanouchi
Nov 26, 2015·Ophthalmic Surgery, Lasers & Imaging Retina·Tamaki GekkaHiroshi Tsuneoka
Jan 1, 2016·JAMA Ophthalmology·Dilraj S Grewal, Tamer H Mahmoud
Oct 27, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yining DaiZhikun Yang
Mar 29, 2018·International Ophthalmology·Chiara De GiacintoDaniele Tognetto

❮ Previous
Next ❯

Citations

Feb 23, 2020·Ophthalmic Surgery, Lasers & Imaging Retina·Hossam M MoharramMohamed Farouk Abdelkader
Aug 21, 2019·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·Christos HaritoglouJoachim Wachtlin
Aug 23, 2020·Journal of Clinical Medicine·Tomaso CaporossiStanislao Rizzo
Sep 25, 2019·Indian Journal of Ophthalmology·Sumit R Singh, Raja Narayanan
Oct 23, 2020·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Xhevat LumiMarko Hawlina
Feb 16, 2021·Current Ophthalmology Reports·Hailey Kay Robles-HolmesJayanth Sridhar
Feb 2, 2021·Journal of Ophthalmology·Alexandre LachanceAli Dirani
Mar 18, 2021·Indian Journal of Ophthalmology·Debdulal ChakrabortySaptorshi Majumdar
Nov 10, 2020·Experimental Eye Research·An-Lun WuChi-Chun Lai
Jun 21, 2019·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Rino FrisinaEdoardo Midena
Feb 11, 2019·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·Rino FrisinaEdoardo Midena
May 15, 2021·Retina·Saagar N PatelBozho Todorich
Jan 5, 2022·Ophthalmic Surgery, Lasers & Imaging Retina·Aneesha KalurRishi P Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.